| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2013 | US8530470 Chromenone derivatives |
| 09/10/2013 | US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 |
| 09/10/2013 | US8530468 Bicyclylaryl-aryl-amine compounds and their use |
| 09/10/2013 | US8530467 Benzoimidazole compounds and uses thereof |
| 09/10/2013 | US8530466 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 09/10/2013 | US8530465 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof |
| 09/10/2013 | US8530463 Multimodal particulate formulations |
| 09/10/2013 | US8530462 Indole modulators of S1P receptors |
| 09/10/2013 | US8530461 Azetidine derivatives |
| 09/10/2013 | US8530460 Azetidine derivatives |
| 09/10/2013 | US8530457 Method for the treatment of lymphangioleiomyomatosis (LAM) |
| 09/10/2013 | US8530456 Sonic hedgehog modulators |
| 09/10/2013 | US8530455 Hemostatic effects of glucono-delta-lactone |
| 09/10/2013 | US8530454 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis |
| 09/10/2013 | US8530453 Compounds and methods for the treatment of pain and other diseases |
| 09/10/2013 | US8530452 Tricyclic boron compounds for antimicrobial therapy |
| 09/10/2013 | US8530451 Method and composition for the control of ectoparasites |
| 09/10/2013 | US8530450 Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics |
| 09/10/2013 | US8530449 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye |
| 09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
| 09/10/2013 | US8530447 Dietary fiber formulation and method of administration |
| 09/10/2013 | US8530446 Oral composition containing difructose anhydride |
| 09/10/2013 | US8530445 Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine |
| 09/10/2013 | US8530444 Pharmaceutical compounds |
| 09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
| 09/10/2013 | US8530435 Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia |
| 09/10/2013 | US8530434 Nitroxide free radical synergized antineoplastic agents |
| 09/10/2013 | US8530433 Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction |
| 09/10/2013 | US8530418 Cytokine containing compositions |
| 09/10/2013 | US8530412 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 09/10/2013 | US8530387 Dithiinopyridazinone derivatives |
| 09/10/2013 | US8530382 Anthranilic diamide compositions for propagule coating |
| 09/10/2013 | US8530209 Method for producing probiotically derived compounds |
| 09/10/2013 | US8529969 Treatment of the guar split with an alkaline solution and hydrogen peroxide, partial neutralization with acid, removal of peripheral cell layers of the guar split, treating split with aqueous alcohol, grinding; clarity; use as thickener |
| 09/10/2013 | US8529968 Decontaminating composition having simultaneously bactericidal, fungicidal and virocidal properties, methods for obtaining and using said composition |
| 09/10/2013 | US8529963 Method for preparing dispersions of precious metal nanoparticles and for isolating such nanoparticles from said dispersions |
| 09/10/2013 | US8529953 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 09/10/2013 | US8529952 improved bioavailabilty; micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant |
| 09/10/2013 | US8529947 Alkaloid formulations |
| 09/10/2013 | US8529946 Rapidly disintegrating antihistamine formulation |
| 09/10/2013 | US8529945 Oral antimicrobial pharmaceutical compositions |
| 09/10/2013 | US8529940 Dietary method for modulating glucose metabolism |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529938 Combinations of viscoelastics for use during surgery |
| 09/10/2013 | US8529935 Antibacterial hydrogel and use thereof in orthopedics |
| 09/10/2013 | US8529928 Biomimetic polymers and uses thereof |
| 09/10/2013 | US8529927 Alpha-2 agonist polymeric drug delivery systems |
| 09/10/2013 | US8529922 Polymer formulations for delivery of bioactive materials |
| 09/10/2013 | US8529917 Micelle encapsulation of a combination of therapeutic agents |
| 09/10/2013 | US8529916 High concentration baclofen preparations |
| 09/10/2013 | US8529915 (R)-(-)-1,2-propanediol compositions and methods |
| 09/10/2013 | US8529914 Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
| 09/10/2013 | US8529900 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer |
| 09/10/2013 | US8529894 Methods of reducing inflammation in cardiomyopathy |
| 09/10/2013 | US8529885 AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | US8529880 Biodegradable polyurethane/urea compositions |
| 09/10/2013 | US8529875 Tobacco alkaloid releasing chewing gum |
| 09/10/2013 | US8529871 in a patient receiving high dose radioactive iodine for treatment of cancer; administering to the eyes of said patient an effective amount of perchlorate anion |
| 09/10/2013 | CA2764542C Disubstituted phthalazine hedgehog pathway antagonists |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2747420C Azaazulene compounds |
| 09/10/2013 | CA2731769C Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 09/10/2013 | CA2723396C Benzene sulfonamide thiazole and oxazole compounds |
| 09/10/2013 | CA2721670C 3-phenylpyrazolo[5,1-b]thiazole compound |
| 09/10/2013 | CA2700690C Process for producing reformatsky reagent in stable form |
| 09/10/2013 | CA2691474C Cyanoisoquinoline |
| 09/10/2013 | CA2673254C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 09/10/2013 | CA2671449C Composite material for tissue repair |
| 09/10/2013 | CA2669687C Phthalazine derivatives |
| 09/10/2013 | CA2650572C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/10/2013 | CA2649256C Therapeutic agent for inflammatory bowel disease |
| 09/10/2013 | CA2649111C Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/10/2013 | CA2633125C Adhesive pharmaceutical preparation containing bisoprolol |
| 09/10/2013 | CA2627982C Soft anticholinergic esters |
| 09/10/2013 | CA2627837C Pharmaceutical compositions for alleviating discomfort |
| 09/10/2013 | CA2619386C Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events |
| 09/10/2013 | CA2614544C Heterocycle-substituted benzimidazole derivative |
| 09/10/2013 | CA2611430C Pharmaceutical compositions of a neuroactive steroid and uses thereof |
| 09/10/2013 | CA2611376C Therapeutic agents |
| 09/10/2013 | CA2608457C Ebselen as a prophylactic or therapeutic agent for corneal or conjunctival disorders |
| 09/10/2013 | CA2604778C Anti-inflammatory and/or analgesic composition for the intestine comprising branched maltodextrins |
| 09/10/2013 | CA2602199C Heteroaryl urea derivatives useful for inhibiting chk1 |
| 09/10/2013 | CA2601357C Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases |
| 09/10/2013 | CA2595522C 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 09/10/2013 | CA2589529C 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 09/10/2013 | CA2588278C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 09/10/2013 | CA2587444C Guanidine derivatives as inhibitors of ddah |
| 09/10/2013 | CA2586597C Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form |
| 09/10/2013 | CA2585934C Novel pyrazolopyridine urea kinase inhibitors |
| 09/10/2013 | CA2583149C Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 09/10/2013 | CA2581316C Substituted chroman derivatives, medicaments and use in therapy |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 09/10/2013 | CA2577588C Hiv inhibiting bicyclic pyrimidine derivatives |
| 09/10/2013 | CA2574301C (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 09/10/2013 | CA2570197C Nk1 antagonists |
| 09/10/2013 | CA2569368C Photochromic material comprising a proteorhodopsin apoprotein and retinal analog |
| 09/10/2013 | CA2566362C Treating seizures using ice inhibitors |